Search

Search Constraints

You searched for: Author/Creator Sugio, Kenji

Search Results

1. A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancer. (October 2018)

2. A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303. (11th December 2017)

3. Clinical significance of part-solid lung cancer in the eighth edition TNM staging system. (25th September 2021)

5. Erlotinib for Non‐Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101). (11th August 2020)

7. Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial. (May 2021)

8. Pemetrexed‐induced scleroderma‐like conditions in the lower legs of a patient with non‐small cell lung carcinoma. Issue 9 (15th March 2016)

9. Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A). Issue 1 (24th November 2016)

10. Phase II study of S‐1 plus cisplatin with concurrent radiotherapy for locally advanced thymic carcinoma: Results of the LOGIK1605/JART‐1501 study. Issue 17 (22nd July 2022)